The clinical and pathological phenotypes of frontotemporal dementia with C9ORF72 mutations

Journal of the Neurological Sciences

Volumn 335, Issue 1-2, 2013, Pages 26-35

  Liu, Ying ^a   Yu, Jin Tai ^b   Sun, Fu Rong ^b   Ou, Jiang Rong ^b   Qu, Song Ben ^c   Tan, Lan ^a,b  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b QINGDAO UNIVERSITY   (China)

^c Qingdao Central Hospital   (China)

Author keywords

C9ORF92; Frontotemporal dementia; Genetics TDP 43; Mutation; Pathology; Phenotype

Indexed keywords

APOLIPOPROTEIN E; PROTEIN P62; RNA BINDING PROTEIN; RNA BINDING PROTEIN 45; TAR DNA BINDING PROTEIN; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; CELL INCLUSION; CEREBELLUM; COHORT ANALYSIS; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; FRONTAL VARIANT FRONTOTEMPORAL DEMENTIA; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; HIPPOCAMPUS; HUMAN; HYPOTHESIS; MICROGLIA; NEOCORTEX; NEUROIMAGING; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NONHUMAN; PHENOTYPE; PRIMARY PROGRESSIVE APHASIA; PRIORITY JOURNAL; PURKINJE CELL; REVIEW; RNA TRANSLATION;

C9ORF92; FRONTOTEMPORAL DEMENTIA; GENETICS TDP-43; MUTATION; PATHOLOGY; PHENOTYPE;

AGE OF ONSET; DNA-BINDING PROTEINS; FAMILY HEALTH; FRONTOTEMPORAL DEMENTIA; HUMANS; MUTATION; PHENOTYPE; PROTEINS;

EID: 84888138605     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2013.09.013     Document Type: Review

References (106)

1. J.S. Snowden, D. Neary, and D.M. Mann Frontotemporal dementia Br J Psychiatry 180 2002 140 143
2. C. Cerami, E. Scarpini, S.F. Cappa, and D. Galimberti Frontotemporal lobar degeneration: current knowledge and future challenges J Neurol 259 2012 2278 2286
3. G.D. Rabinovici, and B.L. Miller Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management CNS Drugs 24 2010 375 398
4. D. Neary, and J. Snowden Frontal lobe dementia, motor neuron disease, and clinical and neuropathological criteria J Neurol Neurosurg Psychiatry 84 2013 713 714
5. O. Piguet, M. Hornberger, E. Mioshi, and J.R. Hodges Behavioural-variant frontotemporal dementia: diagnosis, clinical staging, and management Lancet Neurol 10 2011 162 172
6. I.R. Mackenzie, M. Neumann, E.H. Bigio, N.J. Cairns, I. Alafuzoff, and J. Kril Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update Acta Neuropathol 119 2010 1 4
7. K.A. Josephs, J.R. Hodges, J.S. Snowden, I.R. Mackenzie, M. Neumann, and D.M. Mann Neuropathological background of phenotypical variability in frontotemporal dementia Acta Neuropathol 122 2011 137 153
8. M. DeJesus-Hernandez, I.R. Mackenzie, B.F. Boeve, A.L. Boxer, M. Baker, and N.J. Rutherford Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS Neuron 72 2011 245 256
9. A.E. Renton, E. Majounie, A. Waite, J. Simon-Sanchez, S. Rollinson, and J.R. Gibbs A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD Neuron 72 2011 257 268
10. H. Stewart, N.J. Rutherford, H. Briemberg, C. Krieger, N. Cashman, and M. Fabros Clinical and pathological features of amyotrophic lateral sclerosis caused by mutation in the C9ORF72 gene on chromosome 9p Acta Neuropathol 123 2012 409 417
11. M.E. Murray, M. DeJesus-Hernandez, N.J. Rutherford, M. Baker, R. Duara, and N.R. Graff-Radford Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72 Acta Neuropathol 122 2011 673 690
12. C. Lomen-Hoerth, J. Murphy, S. Langmore, J.H. Kramer, R.K. Olney, and B. Miller Are amyotrophic lateral sclerosis patients cognitively normal? Neurology 60 2003 1094 1097
13. J.S. Goldman, J.M. Farmer, E.M. Wood, J.K. Johnson, A. Boxer, and J. Neuhaus Comparison of family histories in FTLD subtypes and related tauopathies Neurology 65 2005 1817 1819
14. T. Bird, D. Knopman, J. VanSwieten, S. Rosso, H. Feldman, and H. Tanabe Epidemiology and genetics of frontotemporal dementia/Pick's disease Ann Neurol 54 Suppl. 5 2003 S29 S31
15. S.M. Pickering-Brown The complex aetiology of frontotemporal lobar degeneration Exp Neurol 206 2007 1 10
16. M. Hutton, C.L. Lendon, P. Rizzu, M. Baker, S. Froelich, and H. Houlden Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17 Nature 393 1998 702 705
17. M.G. Spillantini, J.R. Murrell, M. Goedert, M.R. Farlow, A. Klug, and B. Ghetti Mutation in the tau gene in familial multiple system tauopathy with presenile dementia Proc Natl Acad Sci U S A 95 1998 7737 7741
18. S.M. Pickering-Brown, S. Rollinson, D. Du Plessis, K.E. Morrison, A. Varma, and A.M. Richardson Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations Brain 131 2008 721 731
19. P. Poorkaj, M. Grossman, E. Steinbart, H. Payami, A. Sadovnick, and D. Nochlin Frequency of tau gene mutations in familial and sporadic cases of non-Alzheimer dementia Arch Neurol 58 2001 383 387
20. H. Seelaar, K.Y. Klijnsma, I. de Koning, A. van der Lugt, W.Z. Chiu, and A. Azmani Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degeneration J Neurol 257 2010 747 753
21. S. Gydesen, J.M. Brown, A. Brun, L. Chakrabarti, A. Gade, and P. Johannsen Chromosome 3 linked frontotemporal dementia (FTD-3) Neurology 59 2002 1585 1594
22. G.D. Watts, J. Wymer, M.J. Kovach, S.G. Mehta, S. Mumm, and D. Darvish Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein Nat Genet 36 2004 377 381
23. M. Baker, I.R. Mackenzie, S.M. Pickering-Brown, J. Gass, R. Rademakers, and C. Lindholm Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17 Nature 442 2006 916 919
24. M. Cruts, I. Gijselinck, J. van der Zee, S. Engelborghs, H. Wils, and D. Pirici Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21 Nature 442 2006 920 924
25. I.R. Mackenzie, M. Baker, G. West, J. Woulfe, N. Qadi, and J. Gass A family with tau-negative frontotemporal dementia and neuronal intranuclear inclusions linked to chromosome 17 Brain 129 2006 853 867
26. L. Benajiba, I. Le Ber, A. Camuzat, M. Lacoste, C. Thomas-Anterion, and P. Couratier TARDBP mutations in motoneuron disease with frontotemporal lobar degeneration Ann Neurol 65 2009 470 473
27. T. Van Langenhove, J. van der Zee, K. Sleegers, S. Engelborghs, R. Vandenberghe, and I. Gijselinck Genetic contribution of FUS to frontotemporal lobar degeneration Neurology 74 2010 366 371
28. O. Broustal, A. Camuzat, L. Guillot-Noel, N. Guy, S. Millecamps, and D. Deffond FUS mutations in frontotemporal lobar degeneration with amyotrophic lateral sclerosis J Alzheimers Dis 22 2010 765 769
29. J. Yan, H.X. Deng, N. Siddique, F. Fecto, W. Chen, and Y. Yang Frameshift and novel mutations in FUS in familial amyotrophic lateral sclerosis and ALS/dementia Neurology 75 2010 807 814
30. I. Le Ber, A. Camuzat, L. Guillot-Noel, D. Hannequin, L. Lacomblez, and V. Golfier C9ORF72 repeat expansions in the frontotemporal dementias spectrum of diseases: a flowchart for genetic testing J Alzheimers Dis 34 2013 485 499
31. C.C. Weihl Valosin containing protein associated fronto-temporal lobar degeneration: clinical presentation, pathologic features and pathogenesis Curr Alzheimer Res 8 2011 252 260
32. N.J. Rutherford, M.G. Heckman, M. Dejesus-Hernandez, M.C. Baker, A.I. Soto-Ortolaza, and S. Rayaprolu Length of normal alleles of C9ORF72 GGGGCC repeat do not influence disease phenotype Neurobiol Aging 33 2012 2950 [e5-7]
33. M.B. Harms, J. Cady, C. Zaidman, P. Cooper, T. Bali, and P. Allred Lack of C9ORF72 coding mutations supports a gain of function for repeat expansions in amyotrophic lateral sclerosis Neurobiol Aging 34 2013 79 82
34. A. Garcia-Redondo, O. Dols-Icardo, R. Rojas-Garcia, J. Esteban-Perez, P. Cordero-Vazquez, and J.L. Munoz-Blanco Analysis of the C9orf72 gene in patients with amyotrophic lateral sclerosis in Spain and different populations worldwide Hum Mutat 34 2013 79 82
35. C.J. Mahoney, J. Beck, J.D. Rohrer, T. Lashley, K. Mok, and T. Shakespeare Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features Brain 135 2012 736 750
36. J.S. Snowden, S. Rollinson, J.C. Thompson, J.M. Harris, C.L. Stopford, and A.M. Richardson Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations Brain 135 2012 693 708
37. J. Brettschneider, V.M. Van Deerlin, J.L. Robinson, L. Kwong, E.B. Lee, and Y.O. Ali Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion Acta Neuropathol 123 2012 825 839
38. G.Y. Hsiung, M. DeJesus-Hernandez, H.H. Feldman, P. Sengdy, P. Bouchard-Kerr, and E. Dwosh Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p Brain 135 2012 709 722
39. I. Gijselinck, T. Van Langenhove, J. van der Zee, K. Sleegers, S. Philtjens, and G. Kleinberger A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study Lancet Neurol 11 2012 54 65
40. E. Majounie, A.E. Renton, K. Mok, E.G. Dopper, A. Waite, and S. Rollinson Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study Lancet Neurol 11 2012 323 330
41. J. Simon-Sanchez, E.G. Dopper, P.E. Cohn-Hokke, R.K. Hukema, N. Nicolaou, and H. Seelaar The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions Brain 135 2012 723 735
42. B.F. Boeve, K.B. Boylan, N.R. Graff-Radford, M. DeJesus-Hernandez, D.S. Knopman, and O. Pedraza Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72 Brain 135 2012 765 783
43. J.D. Rohrer, and J.D. Warren Phenotypic signatures of genetic frontotemporal dementia Curr Opin Neurol 24 2011 542 549
44. S. Ciura, S. Lattante, I. Le Ber, M. Latouche, H. Tostivint, and A. Brice Loss of function of C9orf72 causes motor deficits in a zebrafish model of Amyotrophic Lateral Sclerosis Ann Neurol 74 2013 180 187
45. M. van Blitterswijk, M. DeJesus-Hernandez, and R. Rademakers How do C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia: can we learn from other noncoding repeat expansion disorders? Curr Opin Neurol 25 2012 689 700
46. P.E. Ash, K.F. Bieniek, T.F. Gendron, T. Caulfield, W.L. Lin, and M. Dejesus-Hernandez Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS Neuron 77 2013 639 646
47. K. Mori, S.M. Weng, T. Arzberger, S. May, K. Rentzsch, and E. Kremmer The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS Science 339 2013 1335 1338
48. J. Cooper-Knock, C. Hewitt, J.R. Highley, A. Brockington, A. Milano, and S. Man Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72 Brain 135 2012 751 764
49. B.A. Yankner, T. Lu, and P. Loerch The aging brain Annu Rev Pathol 3 2008 41 66
50. M. Neumann, D.M. Sampathu, L.K. Kwong, A.C. Truax, M.C. Micsenyi, and T.T. Chou Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis Science 314 2006 130 133
51. I.R. Mackenzie, M. Neumann, A. Baborie, D.M. Sampathu, D. Du Plessis, and E. Jaros A harmonized classification system for FTLD-TDP pathology Acta Neuropathol 122 2011 111 113
52. T. Arai, M. Hasegawa, H. Akiyama, K. Ikeda, T. Nonaka, and H. Mori TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis Biochem Biophys Res Commun 351 2006 602 611
53. M. Neumann, R. Rademakers, S. Roeber, M. Baker, H.A. Kretzschmar, and I.R. Mackenzie A new subtype of frontotemporal lobar degeneration with FUS pathology Brain 132 2009 2922 2931
54. C. Lagier-Tourenne, M. Polymenidou, and D.W. Cleveland TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration Hum Mol Genet 19 2010 R46 R64
55. A.L. Boxer, I.R. Mackenzie, B.F. Boeve, M. Baker, W.W. Seeley, and R. Crook Clinical, neuroimaging and neuropathological features of a new chromosome 9p-linked FTD-ALS family J Neurol Neurosurg Psychiatry 82 2011 196 203
56. E. Englund, L. Gustafson, U. Passant, E. Majounie, A.E. Renton, and B.J. Traynor Familial Lund frontotemporal dementia caused by C9ORF72 hexanucleotide expansion Neurobiol Aging 33 2012 1850 [e13-6]
57. J. van der Zee, I. Gijselinck, L. Dillen, T. Van Langenhove, J. Theuns, and S. Engelborghs A Pan-European study of the C9orf72 repeat associated with FTLD: geographic prevalence, genomic instability, and intermediate repeats Hum Mutat 34 2013 363 373
58. C. Dobson-Stone, M. Hallupp, L. Bartley, C.E. Shepherd, G.M. Halliday, and P.R. Schofield C9ORF72 repeat expansion in clinical and neuropathologic frontotemporal dementia cohorts Neurology 79 2012 995 1001
59. E.H. Bigio, S. Weintraub, R. Rademakers, M. Baker, S.S. Ahmadian, and A. Rademaker Frontotemporal lobar degeneration with TDP-43 proteinopathy and chromosome 9p repeat expansion in C9ORF72: clinicopathologic correlation Neuropathology 33 2013 122 133
60. D.J. Irwin, C.T. McMillan, J. Brettschneider, D.J. Libon, J. Powers, and K. Rascovsky Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosis J Neurol Neurosurg Psychiatry 84 2013 163 169
61. S. Al-Sarraj, A. King, C. Troakes, B. Smith, S. Maekawa, and I. Bodi p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS Acta Neuropathol 122 2011 691 702
62. C. Troakes, S. Maekawa, L. Wijesekera, B. Rogelj, L. Siklos, and C. Bell An MND/ALS phenotype associated with C9orf72 repeat expansion: abundant p62-positive, TDP-43-negative inclusions in cerebral cortex, hippocampus and cerebellum but without associated cognitive decline Neuropathology 32 2012 505 514
63. A. King, S. Al-Sarraj, C. Troakes, B.N. Smith, S. Maekawa, and M. Iovino Mixed tau, TDP-43 and p62 pathology in FTLD associated with a C9ORF72 repeat expansion and p.Ala239Thr MAPT (tau) variant Acta Neuropathol 125 2013 303 310
64. H. Daoud, H. Suhail, M. Sabbagh, V. Belzil, A. Szuto, and A. Dionne-Laporte C9orf72 hexanucleotide repeat expansions as the causative mutation for chromosome 9p21-linked amyotrophic lateral sclerosis and frontotemporal dementia Arch Neurol 69 2012 1159 1163
65. Ilse Gijselinck, L.T. Van, Julie van der Zee, Kristel Sleegers, Stéphanie Philtjens, and Gernot Kleinberger A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum Lancet Neurol 11 2012 11
66. J. Cooper-Knock, J.R. Highley, J. Hartley, A. Milano, S. Sawcer, and A. Compston Neurodegeneration caused by intronic expansions of C9ORF72 is a clinically heterogeneous but pathologically distinct disease Lancet 381 2013 S32
67. K.F. Bieniek, M.E. Murray, N.J. Rutherford, M. Castanedes-Casey, M. DeJesus-Hernandez, and A.M. Liesinger Tau pathology in frontotemporal lobar degeneration with C9ORF72 hexanucleotide repeat expansion Acta Neuropathol 125 2013 289 302
68. M. Cruts, I. Gijselinck, T. Van Langenhove, J. van der Zee, and C. Van Broeckhoven Current insights into the C9orf72 repeat expansion diseases of the FTLD/ALS spectrum Trends Neurosci 36 2013 450 459
69. T. Zu, B. Gibbens, N.S. Doty, M. Gomes-Pereira, A. Huguet, and M.D. Stone Non-ATG-initiated translation directed by microsatellite expansions Proc Natl Acad Sci U S A 108 2011 260 265
70. J. Brettschneider, J.B. Toledo, V.M. Van Deerlin, L. Elman, L. McCluskey, and V.M. Lee Microglial activation correlates with disease progression and upper motor neuron clinical symptoms in amyotrophic lateral sclerosis PLoS One 7 2012 e39216
71. M. Collins, D. Riascos, T. Kovalik, J. An, K. Krupa, and B.L. Hood The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients Acta Neuropathol 124 2012 717 732
72. F. Agosta, K.A. Vossel, B.L. Miller, R. Migliaccio, S.J. Bonasera, and M. Filippi Apolipoprotein E epsilon4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia Proc Natl Acad Sci U S A 106 2009 2018 2022
73. K.A. Vossel, N. Bien-Ly, A. Bernardo, K. Rascovsky, A. Karydas, and G.D. Rabinovici ApoE and TDP-43 neuropathology in two siblings with familial FTLD-motor neuron disease Neurocase 19 2013 295 301
74. N. Finch, M.M. Carrasquillo, M. Baker, N.J. Rutherford, G. Coppola, and M. Dejesus-Hernandez TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers Neurology 76 2011 467 474
75. O. Dols-Icardo, M. Suárez-Calvet, I. Hernández, G. Amer, S. Antón-Aguirre, and D. Alcolea Expansion mutation in C9ORF72 does not influence plasma progranulin levels in frontotemporal dementia Neurobiol Aging 33 2012 1851 [e17-e19]
76. R. Ghidoni, L. Benussi, M. Glionna, M. Franzoni, and G. Binetti Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration Neurology 71 2008 1235 1239
77. S. Rollinson, N. Halliwell, K. Young, J.B. Callister, G. Toulson, and L. Gibbons Analysis of the hexanucleotide repeat in C9ORF72 in Alzheimer's disease Neurobiol Aging 33 2012 1846e5 1846e6
78. B.A. Hosler, T. Siddique, P.C. Sapp, W. Sailor, M.C. Huang, and A. Hossain Linkage of familial amyotrophic lateral sclerosis with frontotemporal dementia to chromosome 9q21-q22 JAMA 284 2000 1664 1669
79. Z. Xi, L. Zinman, Y. Grinberg, D. Moreno, C. Sato, and J.M. Bilbao Investigation of C9orf72 in 4 neurodegenerative disorders Arch Neurol 2012 1 8
80. B.N. Smith, S. Newhouse, A. Shatunov, C. Vance, S. Topp, and L. Johnson The C9ORF72 expansion mutation is a common cause of ALS+/-FTD in Europe and has a single founder Eur J Hum Genet 21 2013 102 108
81. J.S. Snowden, J. Harris, A. Richardson, S. Rollinson, J.C. Thompson, and D. Neary Frontotemporal dementia with amyotrophic lateral sclerosis: a clinical comparison of patients with and without repeat expansions in C9orf72 Amyotroph Lateral Scler Frontotemporal Degener 14 2013 172 176
82. B.K. Khan, J.S. Yokoyama, L.T. Takada, S.J. Sha, N.J. Rutherford, and J.C. Fong Atypical, slowly progressive behavioural variant frontotemporal dementia associated with C9ORF72 hexanucleotide expansion J Neurol Neurosurg Psychiatry 83 2012 358 364
83. A. Arighi, G.G. Fumagalli, F. Jacini, C. Fenoglio, L. Ghezzi, and A.M. Pietroboni Early onset behavioral variant frontotemporal dementia due to the C9ORF72 hexanucleotide repeat expansion: psychiatric clinical presentations J Alzheimers Dis 31 2012 447 452
84. R. Savica, A. Adeli, P. Vemuri, D.S. Knopman, M. Dejesus-Hernandez, and R. Rademakers Characterization of a family with c9FTD/ALS associated with the GGGGCC repeat expansion in C9ORF72 Arch Neurol 69 2012 1164 1169
85. J.P. Pearson, N.M. Williams, E. Majounie, A. Waite, J. Stott, and V. Newsway Familial frontotemporal dementia with amyotrophic lateral sclerosis and a shared haplotype on chromosome 9p J Neurol 258 2011 647 655
86. D. Galimberti, C. Fenoglio, M. Serpente, C. Villa, R. Bonsi, and A. Arighi Autosomal dominant frontotemporal lobar degeneration due to the C9ORF72 hexanucleotide repeat expansion: late-onset psychotic clinical presentation Biol Psychiatry 74 2013 384 391
87. M. Synofzik, S. Biskup, T. Leyhe, M. Reimold, A.J. Fallgatter, and F. Metzger Suicide attempt as the presenting symptom of C9orf72 dementia Am J Psychiatry 169 2012 1211 1213
88. L.E. Downey, C.J. Mahoney, M.N. Rossor, S.J. Crutch, and J.D. Warren Impaired self-other differentiation in frontotemporal dementia due to the C9ORF72 expansion Alzheimers Res Ther 4 2012 42
89. J. Phukan, N.P. Pender, and O. Hardiman Cognitive impairment in amyotrophic lateral sclerosis Lancet Neurol 6 2007 994 1003
90. G.M. Ringholz, S.H. Appel, M. Bradshaw, N.A. Cooke, D.M. Mosnik, and P.E. Schulz Prevalence and patterns of cognitive impairment in sporadic ALS Neurology 65 2005 586 590
91. Y. Iwasaki, M. Kinoshita, K. Ikeda, K. Takamiya, and T. Shiojima Cognitive impairment in amyotrophic lateral sclerosis and its relation to motor disabilities Acta Neurol Scand 81 1990 141 143
92. T. van Langenhove, J. van der Zee, and C. van Broeckhoven The molecular basis of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum Ann Med 44 2012 817 828
93. H.R. Morris, A.J. Waite, N.M. Williams, J.W. Neal, and D.J. Blake Recent advances in the genetics of the ALS-FTLD complex Curr Neurol Neurosci Rep 12 2012 243 250
94. R.P. Friedland, J.J. Shah, L.A. Farrer, B. Vardarajan, J.D. Rebolledo-Mendez, and K. Mok Behavioral variant frontotemporal lobar degeneration with amyotrophic lateral sclerosis with a chromosome 9p21 hexanucleotide repeat Front Neurol 3 2012 136
95. R. Pamphlett, P.L. Cheong, R.J. Trent, and B. Yu Transmission of C9orf72 hexanucleotide repeat expansions in sporadic amyotrophic lateral sclerosis: an Australian trio study Neuroreport 23 2012 556 559
96. M.H. Martikainen, M. Gardberg, L. Jansson, M. Roytta, J.O. Rinne, and V. Kaasinen Brain (18)F-FDG and (11)C-PiB PET findings in two siblings with FTD/ALS associated with the C9ORF72 repeat expansion Neurocase 2012 (in press)
97. E. Majounie, Y. Abramzon, A.E. Renton, R. Perry, S.S. Bassett, and O. Pletnikova Repeat expansion in C9ORF72 in Alzheimer's disease N Engl J Med 366 2012 283 284
98. D. Wallon, A. Rovelet-Lecrux, V. Deramecourt, J. Pariente, S. Auriacombe, and I. Le Ber Definite behavioral variant of frontotemporal dementia with C9ORF72 expansions despite positive Alzheimer's disease cerebrospinal fluid biomarkers J Alzheimers Dis 32 2012 19 22
99. J. Beck, M. Poulter, D. Hensman, J.D. Rohrer, C.J. Mahoney, and G. Adamson Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population Am J Hum Genet 92 2013 345 353
100. M.A. Kohli, K. John-Williams, R. Rajbhandary, A. Naj, P. Whitehead, and K. Hamilton Repeat expansions in the C9ORF72 gene contribute to Alzheimer's disease in Caucasians Neurobiol Aging 34 2013 1519e5 12
101. S. Rollinson, N. Halliwell, K. Young, J.B. Callister, G. Toulson, and L. Gibbons Analysis of the hexanucleotide repeat in C9ORF72 in Alzheimer's disease Neurobiol Aging 33 2012 1846 [e5-6]
102. R. Cacace, C. Van Cauwenberghe, K. Bettens, I. Gijselinck, J. van der Zee, and S. Engelborghs C9orf72 G4C2 repeat expansions in Alzheimer's disease and mild cognitive impairment Neurobiol Aging 34 2013 1712 [e1-7]
103. M. Harms, B.A. Benitez, N. Cairns, B. Cooper, P. Cooper, and K. Mayo C9orf72 hexanucleotide repeat expansions in clinical Alzheimer disease JAMA Neurol 2013 1 6
104. Y. Liu, J.-T. Yu, Y. Zong, J. Zhou, and L. Tan C9ORF72 mutations in neurodegenerative diseases Mol Neurobiol 2013 1 13
105. J.L. Whitwell, S.D. Weigand, B.F. Boeve, M.L. Senjem, J.L. Gunter, and M. DeJesus-Hernandez Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics Brain 135 2012 794 806
106. J.L. Whitwell, J. Xu, J. Mandrekar, B.F. Boeve, D.S. Knopman, and J.E. Parisi Frontal asymmetry in behavioral variant frontotemporal dementia: clinicoimaging and pathogenetic correlates Neurobiol Aging 34 2013 636 639